South Shore Capital Advisors

Position in PFE — Pfizer Inc

CIK 1852993 COHASSET, MA

Position in PFE

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$208,340

-$34,299 QoQ

Shares Held

8,652

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#2,427

of 2,821 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

South Shore Capital Advisors holds $5,027,059 across 5 Drug Manufacturers - General names. PFE ranks #5 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	13,605	$3,455,261
2	LLY	ELI LILLY & Co	387	$464,179
3	NVS	Novartis AG	2,870	$449,786
4	MRK	Merck & Co., Inc.	3,498	$449,493
5	PFE	Pfizer Inc This page	8,652	$208,340

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$208,340	8,652	+0.1%	Shares	Sole	2026-07-30
2026-03-31	$242,639	8,641	-59.1%	Shares	Sole	2026-04-28
2022-09-30	$923,467	21,103	-5.0%	Shares	Sole	2022-10-17
2022-06-30	$1,164,103	22,203	+6.0%	Shares	Sole	2022-10-17
2022-03-31	$1,084,219	20,943	+15.8%	Shares	Sole	2022-04-19
2021-12-31	$1,067,505	18,078	+12.7%	Shares	Sole	2022-02-11
2021-09-30	$689,794	16,038	+20.6%	Shares	Sole	2021-10-19
2021-06-30	$520,945	13,303	+10.0%	Shares	Sole	2021-07-29
2021-03-31	$437,984	12,089	—	Shares	Sole	2021-05-07
No filing history on record for this holder in this stock.